The Enterprise Value as of November 2024 (TTM) for Atai Life Sciences N.V. (ATAI) is 164.47M

According to Atai Life Sciences N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 164.47M. This represents a change of -20.20% compared to the average of 206.11M of the last 4 quarters.

Atai Life Sciences N.V. (ATAI) Historical Enterprise Value (quarterly & annually)

How has ATAI Enterprise Value performed in the past?

The mean historical Enterprise Value of Atai Life Sciences N.V. over the last ten years is 259.31M. The current 164.47M Enterprise Value has changed 6.24% with respect to the historical average. Over the past ten years (40 quarters), ATAI's Enterprise Value was at its highest in in the December 2020 quarter at 2.87B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Atai Life Sciences N.V. (ATAI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Atai Life Sciences N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Atai Life Sciences N.V. (ATAI) Average Enterprise Value

How has ATAI Enterprise Value performed in the past?

The current Enterprise Value of Atai Life Sciences N.V. (ATAI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Atai Life Sciences N.V. (ATAI) Enterprise Value vs. Peers

How is ATAI’s Enterprise Value compared to its peers?

Atai Life Sciences N.V.’s Enterprise Value is less than Mind Medicine (MindMed) Inc. (225.51M), greater than Seelos Therapeutics, Inc. (10.40M), less than GH Research PLC (329.85M), greater than Freeline Therapeutics Holdings plc (2.82M), greater than Cybin Inc. (97.98M), greater than Fortress Biotech, Inc. (59.91M), greater than Bio-Path Holdings, Inc. (-340985.00), greater than Vaccinex, Inc. (8.95M), greater than Eliem Therapeutics, Inc. (119.64M), less than Opthea Limited (656.58M), greater than Molecular Partners AG (57.67M), less than Edgewise Therapeutics, Inc. (3.19B), greater than iTeos Therapeutics, Inc. (82.02M), greater than Wesana Health Holdings Inc. (358.19K), greater than BioVaxys Technology Corp. (18.80M), greater than Algernon Pharmaceuticals Inc. (1.23M), greater than AXIM Biotechnologies, Inc. (7.85M),

Build a custom stock screener for Atai Life Sciences N.V. (ATAI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atai Life Sciences N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Atai Life Sciences N.V. (ATAI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Atai Life Sciences N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.